Global Oligonucleotide Synthesis Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.
According to our (Global Info Research) latest study, the global Oligonucleotide Synthesis market size was valued at USD 1910 million in 2022 and is forecast to a readjusted size of USD 2895.7 million by 2029 with a CAGR of 6.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.
This report is a detailed and comprehensive analysis for global Oligonucleotide Synthesis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oligonucleotide Synthesis market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oligonucleotide Synthesis market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oligonucleotide Synthesis market size and forecasts, by Type and by End User, in consumption value ($ Million), 2018-2029
Global Oligonucleotide Synthesis market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oligonucleotide Synthesis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oligonucleotide Synthesis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Integrated DNA Technologies, Merck, Eurofins Genomics, Thermo Fisher Scientific and Agilent Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oligonucleotide Synthesis market is split by Type and by End User. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Oligonucleotide Synthesis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oligonucleotide Synthesis, with revenue, gross margin and global market share of Oligonucleotide Synthesis from 2018 to 2023.
Chapter 3, the Oligonucleotide Synthesis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oligonucleotide Synthesis market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oligonucleotide Synthesis.
Chapter 13, to describe Oligonucleotide Synthesis research findings and conclusion.
According to our (Global Info Research) latest study, the global Oligonucleotide Synthesis market size was valued at USD 1910 million in 2022 and is forecast to a readjusted size of USD 2895.7 million by 2029 with a CAGR of 6.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.
This report is a detailed and comprehensive analysis for global Oligonucleotide Synthesis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oligonucleotide Synthesis market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oligonucleotide Synthesis market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oligonucleotide Synthesis market size and forecasts, by Type and by End User, in consumption value ($ Million), 2018-2029
Global Oligonucleotide Synthesis market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oligonucleotide Synthesis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oligonucleotide Synthesis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Integrated DNA Technologies, Merck, Eurofins Genomics, Thermo Fisher Scientific and Agilent Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oligonucleotide Synthesis market is split by Type and by End User. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Custom Oligonucleotides
- Pre-designed Oligonucleotides
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Others
- Integrated DNA Technologies
- Merck
- Eurofins Genomics
- Thermo Fisher Scientific
- Agilent Technologies
- Eurogentec
- GE Healthcare
- LGC Biosearch Technologies
- Nitto Denko Avecia
- Genscript
- Genedesign
- TriLink Biotechnologies
- Bio-Synthesis
- ATDBio
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Oligonucleotide Synthesis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oligonucleotide Synthesis, with revenue, gross margin and global market share of Oligonucleotide Synthesis from 2018 to 2023.
Chapter 3, the Oligonucleotide Synthesis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oligonucleotide Synthesis market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oligonucleotide Synthesis.
Chapter 13, to describe Oligonucleotide Synthesis research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Oligonucleotide Synthesis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oligonucleotide Synthesis by Type
1.3.1 Overview: Global Oligonucleotide Synthesis Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oligonucleotide Synthesis Consumption Value Market Share by Type in 2022
1.3.3 Custom Oligonucleotides
1.3.4 Pre-designed Oligonucleotides
1.4 Global Oligonucleotide Synthesis Market by End User
1.4.1 Overview: Global Oligonucleotide Synthesis Market Size by End User: 2018 Versus 2022 Versus 2029
1.4.2 Academic Research Institutes
1.4.3 Pharmaceutical and Biotechnology Companies
1.4.4 Diagnostic Laboratories
1.4.5 Others
1.5 Global Oligonucleotide Synthesis Market Size & Forecast
1.6 Global Oligonucleotide Synthesis Market Size and Forecast by Region
1.6.1 Global Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oligonucleotide Synthesis Market Size by Region, (2018-2029)
1.6.3 North America Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
1.6.4 Europe Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
1.6.6 South America Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Integrated DNA Technologies
2.1.1 Integrated DNA Technologies Details
2.1.2 Integrated DNA Technologies Major Business
2.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Product and Solutions
2.1.4 Integrated DNA Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Integrated DNA Technologies Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Oligonucleotide Synthesis Product and Solutions
2.2.4 Merck Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments and Future Plans
2.3 Eurofins Genomics
2.3.1 Eurofins Genomics Details
2.3.2 Eurofins Genomics Major Business
2.3.3 Eurofins Genomics Oligonucleotide Synthesis Product and Solutions
2.3.4 Eurofins Genomics Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Eurofins Genomics Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Product and Solutions
2.4.4 Thermo Fisher Scientific Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Agilent Technologies
2.5.1 Agilent Technologies Details
2.5.2 Agilent Technologies Major Business
2.5.3 Agilent Technologies Oligonucleotide Synthesis Product and Solutions
2.5.4 Agilent Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agilent Technologies Recent Developments and Future Plans
2.6 Eurogentec
2.6.1 Eurogentec Details
2.6.2 Eurogentec Major Business
2.6.3 Eurogentec Oligonucleotide Synthesis Product and Solutions
2.6.4 Eurogentec Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eurogentec Recent Developments and Future Plans
2.7 GE Healthcare
2.7.1 GE Healthcare Details
2.7.2 GE Healthcare Major Business
2.7.3 GE Healthcare Oligonucleotide Synthesis Product and Solutions
2.7.4 GE Healthcare Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GE Healthcare Recent Developments and Future Plans
2.8 LGC Biosearch Technologies
2.8.1 LGC Biosearch Technologies Details
2.8.2 LGC Biosearch Technologies Major Business
2.8.3 LGC Biosearch Technologies Oligonucleotide Synthesis Product and Solutions
2.8.4 LGC Biosearch Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LGC Biosearch Technologies Recent Developments and Future Plans
2.9 Nitto Denko Avecia
2.9.1 Nitto Denko Avecia Details
2.9.2 Nitto Denko Avecia Major Business
2.9.3 Nitto Denko Avecia Oligonucleotide Synthesis Product and Solutions
2.9.4 Nitto Denko Avecia Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nitto Denko Avecia Recent Developments and Future Plans
2.10 Genscript
2.10.1 Genscript Details
2.10.2 Genscript Major Business
2.10.3 Genscript Oligonucleotide Synthesis Product and Solutions
2.10.4 Genscript Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Genscript Recent Developments and Future Plans
2.11 Genedesign
2.11.1 Genedesign Details
2.11.2 Genedesign Major Business
2.11.3 Genedesign Oligonucleotide Synthesis Product and Solutions
2.11.4 Genedesign Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Genedesign Recent Developments and Future Plans
2.12 TriLink Biotechnologies
2.12.1 TriLink Biotechnologies Details
2.12.2 TriLink Biotechnologies Major Business
2.12.3 TriLink Biotechnologies Oligonucleotide Synthesis Product and Solutions
2.12.4 TriLink Biotechnologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TriLink Biotechnologies Recent Developments and Future Plans
2.13 Bio-Synthesis
2.13.1 Bio-Synthesis Details
2.13.2 Bio-Synthesis Major Business
2.13.3 Bio-Synthesis Oligonucleotide Synthesis Product and Solutions
2.13.4 Bio-Synthesis Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bio-Synthesis Recent Developments and Future Plans
2.14 ATDBio
2.14.1 ATDBio Details
2.14.2 ATDBio Major Business
2.14.3 ATDBio Oligonucleotide Synthesis Product and Solutions
2.14.4 ATDBio Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ATDBio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oligonucleotide Synthesis Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oligonucleotide Synthesis by Company Revenue
3.2.2 Top 3 Oligonucleotide Synthesis Players Market Share in 2022
3.2.3 Top 6 Oligonucleotide Synthesis Players Market Share in 2022
3.3 Oligonucleotide Synthesis Market: Overall Company Footprint Analysis
3.3.1 Oligonucleotide Synthesis Market: Region Footprint
3.3.2 Oligonucleotide Synthesis Market: Company Product Type Footprint
3.3.3 Oligonucleotide Synthesis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oligonucleotide Synthesis Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oligonucleotide Synthesis Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY END USER
5.1 Global Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2023)
5.2 Global Oligonucleotide Synthesis Market Forecast by End User (2024-2029)
6 NORTH AMERICA
6.1 North America Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
6.2 North America Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
6.3 North America Oligonucleotide Synthesis Market Size by Country
6.3.1 North America Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
6.3.2 United States Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
6.3.3 Canada Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
6.3.4 Mexico Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
7.2 Europe Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
7.3 Europe Oligonucleotide Synthesis Market Size by Country
7.3.1 Europe Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
7.3.2 Germany Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7.3.3 France Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7.3.5 Russia Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7.3.6 Italy Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
8.3 Asia-Pacific Oligonucleotide Synthesis Market Size by Region
8.3.1 Asia-Pacific Oligonucleotide Synthesis Consumption Value by Region (2018-2029)
8.3.2 China Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.3 Japan Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.4 South Korea Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.5 India Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.7 Australia Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
9.2 South America Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
9.3 South America Oligonucleotide Synthesis Market Size by Country
9.3.1 South America Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
9.3.2 Brazil Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
9.3.3 Argentina Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
10.3 Middle East & Africa Oligonucleotide Synthesis Market Size by Country
10.3.1 Middle East & Africa Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
10.3.2 Turkey Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
10.3.4 UAE Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Oligonucleotide Synthesis Market Drivers
11.2 Oligonucleotide Synthesis Market Restraints
11.3 Oligonucleotide Synthesis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Oligonucleotide Synthesis Industry Chain
12.2 Oligonucleotide Synthesis Upstream Analysis
12.3 Oligonucleotide Synthesis Midstream Analysis
12.4 Oligonucleotide Synthesis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Oligonucleotide Synthesis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oligonucleotide Synthesis by Type
1.3.1 Overview: Global Oligonucleotide Synthesis Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oligonucleotide Synthesis Consumption Value Market Share by Type in 2022
1.3.3 Custom Oligonucleotides
1.3.4 Pre-designed Oligonucleotides
1.4 Global Oligonucleotide Synthesis Market by End User
1.4.1 Overview: Global Oligonucleotide Synthesis Market Size by End User: 2018 Versus 2022 Versus 2029
1.4.2 Academic Research Institutes
1.4.3 Pharmaceutical and Biotechnology Companies
1.4.4 Diagnostic Laboratories
1.4.5 Others
1.5 Global Oligonucleotide Synthesis Market Size & Forecast
1.6 Global Oligonucleotide Synthesis Market Size and Forecast by Region
1.6.1 Global Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oligonucleotide Synthesis Market Size by Region, (2018-2029)
1.6.3 North America Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
1.6.4 Europe Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
1.6.6 South America Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oligonucleotide Synthesis Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Integrated DNA Technologies
2.1.1 Integrated DNA Technologies Details
2.1.2 Integrated DNA Technologies Major Business
2.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Product and Solutions
2.1.4 Integrated DNA Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Integrated DNA Technologies Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Oligonucleotide Synthesis Product and Solutions
2.2.4 Merck Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments and Future Plans
2.3 Eurofins Genomics
2.3.1 Eurofins Genomics Details
2.3.2 Eurofins Genomics Major Business
2.3.3 Eurofins Genomics Oligonucleotide Synthesis Product and Solutions
2.3.4 Eurofins Genomics Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Eurofins Genomics Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Product and Solutions
2.4.4 Thermo Fisher Scientific Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Agilent Technologies
2.5.1 Agilent Technologies Details
2.5.2 Agilent Technologies Major Business
2.5.3 Agilent Technologies Oligonucleotide Synthesis Product and Solutions
2.5.4 Agilent Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agilent Technologies Recent Developments and Future Plans
2.6 Eurogentec
2.6.1 Eurogentec Details
2.6.2 Eurogentec Major Business
2.6.3 Eurogentec Oligonucleotide Synthesis Product and Solutions
2.6.4 Eurogentec Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eurogentec Recent Developments and Future Plans
2.7 GE Healthcare
2.7.1 GE Healthcare Details
2.7.2 GE Healthcare Major Business
2.7.3 GE Healthcare Oligonucleotide Synthesis Product and Solutions
2.7.4 GE Healthcare Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GE Healthcare Recent Developments and Future Plans
2.8 LGC Biosearch Technologies
2.8.1 LGC Biosearch Technologies Details
2.8.2 LGC Biosearch Technologies Major Business
2.8.3 LGC Biosearch Technologies Oligonucleotide Synthesis Product and Solutions
2.8.4 LGC Biosearch Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LGC Biosearch Technologies Recent Developments and Future Plans
2.9 Nitto Denko Avecia
2.9.1 Nitto Denko Avecia Details
2.9.2 Nitto Denko Avecia Major Business
2.9.3 Nitto Denko Avecia Oligonucleotide Synthesis Product and Solutions
2.9.4 Nitto Denko Avecia Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nitto Denko Avecia Recent Developments and Future Plans
2.10 Genscript
2.10.1 Genscript Details
2.10.2 Genscript Major Business
2.10.3 Genscript Oligonucleotide Synthesis Product and Solutions
2.10.4 Genscript Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Genscript Recent Developments and Future Plans
2.11 Genedesign
2.11.1 Genedesign Details
2.11.2 Genedesign Major Business
2.11.3 Genedesign Oligonucleotide Synthesis Product and Solutions
2.11.4 Genedesign Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Genedesign Recent Developments and Future Plans
2.12 TriLink Biotechnologies
2.12.1 TriLink Biotechnologies Details
2.12.2 TriLink Biotechnologies Major Business
2.12.3 TriLink Biotechnologies Oligonucleotide Synthesis Product and Solutions
2.12.4 TriLink Biotechnologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TriLink Biotechnologies Recent Developments and Future Plans
2.13 Bio-Synthesis
2.13.1 Bio-Synthesis Details
2.13.2 Bio-Synthesis Major Business
2.13.3 Bio-Synthesis Oligonucleotide Synthesis Product and Solutions
2.13.4 Bio-Synthesis Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bio-Synthesis Recent Developments and Future Plans
2.14 ATDBio
2.14.1 ATDBio Details
2.14.2 ATDBio Major Business
2.14.3 ATDBio Oligonucleotide Synthesis Product and Solutions
2.14.4 ATDBio Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ATDBio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oligonucleotide Synthesis Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oligonucleotide Synthesis by Company Revenue
3.2.2 Top 3 Oligonucleotide Synthesis Players Market Share in 2022
3.2.3 Top 6 Oligonucleotide Synthesis Players Market Share in 2022
3.3 Oligonucleotide Synthesis Market: Overall Company Footprint Analysis
3.3.1 Oligonucleotide Synthesis Market: Region Footprint
3.3.2 Oligonucleotide Synthesis Market: Company Product Type Footprint
3.3.3 Oligonucleotide Synthesis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oligonucleotide Synthesis Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oligonucleotide Synthesis Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY END USER
5.1 Global Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2023)
5.2 Global Oligonucleotide Synthesis Market Forecast by End User (2024-2029)
6 NORTH AMERICA
6.1 North America Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
6.2 North America Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
6.3 North America Oligonucleotide Synthesis Market Size by Country
6.3.1 North America Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
6.3.2 United States Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
6.3.3 Canada Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
6.3.4 Mexico Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
7.2 Europe Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
7.3 Europe Oligonucleotide Synthesis Market Size by Country
7.3.1 Europe Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
7.3.2 Germany Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7.3.3 France Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7.3.5 Russia Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
7.3.6 Italy Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
8.3 Asia-Pacific Oligonucleotide Synthesis Market Size by Region
8.3.1 Asia-Pacific Oligonucleotide Synthesis Consumption Value by Region (2018-2029)
8.3.2 China Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.3 Japan Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.4 South Korea Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.5 India Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
8.3.7 Australia Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
9.2 South America Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
9.3 South America Oligonucleotide Synthesis Market Size by Country
9.3.1 South America Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
9.3.2 Brazil Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
9.3.3 Argentina Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oligonucleotide Synthesis Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oligonucleotide Synthesis Consumption Value by End User (2018-2029)
10.3 Middle East & Africa Oligonucleotide Synthesis Market Size by Country
10.3.1 Middle East & Africa Oligonucleotide Synthesis Consumption Value by Country (2018-2029)
10.3.2 Turkey Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
10.3.4 UAE Oligonucleotide Synthesis Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Oligonucleotide Synthesis Market Drivers
11.2 Oligonucleotide Synthesis Market Restraints
11.3 Oligonucleotide Synthesis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Oligonucleotide Synthesis Industry Chain
12.2 Oligonucleotide Synthesis Upstream Analysis
12.3 Oligonucleotide Synthesis Midstream Analysis
12.4 Oligonucleotide Synthesis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oligonucleotide Synthesis Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oligonucleotide Synthesis Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oligonucleotide Synthesis Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Integrated DNA Technologies Company Information, Head Office, and Major Competitors
Table 6. Integrated DNA Technologies Major Business
Table 7. Integrated DNA Technologies Oligonucleotide Synthesis Product and Solutions
Table 8. Integrated DNA Technologies Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Integrated DNA Technologies Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Oligonucleotide Synthesis Product and Solutions
Table 13. Merck Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Merck Recent Developments and Future Plans
Table 15. Eurofins Genomics Company Information, Head Office, and Major Competitors
Table 16. Eurofins Genomics Major Business
Table 17. Eurofins Genomics Oligonucleotide Synthesis Product and Solutions
Table 18. Eurofins Genomics Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Eurofins Genomics Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Oligonucleotide Synthesis Product and Solutions
Table 23. Thermo Fisher Scientific Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 26. Agilent Technologies Major Business
Table 27. Agilent Technologies Oligonucleotide Synthesis Product and Solutions
Table 28. Agilent Technologies Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Agilent Technologies Recent Developments and Future Plans
Table 30. Eurogentec Company Information, Head Office, and Major Competitors
Table 31. Eurogentec Major Business
Table 32. Eurogentec Oligonucleotide Synthesis Product and Solutions
Table 33. Eurogentec Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Eurogentec Recent Developments and Future Plans
Table 35. GE Healthcare Company Information, Head Office, and Major Competitors
Table 36. GE Healthcare Major Business
Table 37. GE Healthcare Oligonucleotide Synthesis Product and Solutions
Table 38. GE Healthcare Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GE Healthcare Recent Developments and Future Plans
Table 40. LGC Biosearch Technologies Company Information, Head Office, and Major Competitors
Table 41. LGC Biosearch Technologies Major Business
Table 42. LGC Biosearch Technologies Oligonucleotide Synthesis Product and Solutions
Table 43. LGC Biosearch Technologies Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. LGC Biosearch Technologies Recent Developments and Future Plans
Table 45. Nitto Denko Avecia Company Information, Head Office, and Major Competitors
Table 46. Nitto Denko Avecia Major Business
Table 47. Nitto Denko Avecia Oligonucleotide Synthesis Product and Solutions
Table 48. Nitto Denko Avecia Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Nitto Denko Avecia Recent Developments and Future Plans
Table 50. Genscript Company Information, Head Office, and Major Competitors
Table 51. Genscript Major Business
Table 52. Genscript Oligonucleotide Synthesis Product and Solutions
Table 53. Genscript Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Genscript Recent Developments and Future Plans
Table 55. Genedesign Company Information, Head Office, and Major Competitors
Table 56. Genedesign Major Business
Table 57. Genedesign Oligonucleotide Synthesis Product and Solutions
Table 58. Genedesign Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Genedesign Recent Developments and Future Plans
Table 60. TriLink Biotechnologies Company Information, Head Office, and Major Competitors
Table 61. TriLink Biotechnologies Major Business
Table 62. TriLink Biotechnologies Oligonucleotide Synthesis Product and Solutions
Table 63. TriLink Biotechnologies Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. TriLink Biotechnologies Recent Developments and Future Plans
Table 65. Bio-Synthesis Company Information, Head Office, and Major Competitors
Table 66. Bio-Synthesis Major Business
Table 67. Bio-Synthesis Oligonucleotide Synthesis Product and Solutions
Table 68. Bio-Synthesis Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Bio-Synthesis Recent Developments and Future Plans
Table 70. ATDBio Company Information, Head Office, and Major Competitors
Table 71. ATDBio Major Business
Table 72. ATDBio Oligonucleotide Synthesis Product and Solutions
Table 73. ATDBio Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. ATDBio Recent Developments and Future Plans
Table 75. Global Oligonucleotide Synthesis Revenue (USD Million) by Players (2018-2023)
Table 76. Global Oligonucleotide Synthesis Revenue Share by Players (2018-2023)
Table 77. Breakdown of Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Oligonucleotide Synthesis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key Oligonucleotide Synthesis Players
Table 80. Oligonucleotide Synthesis Market: Company Product Type Footprint
Table 81. Oligonucleotide Synthesis Market: Company Product Application Footprint
Table 82. Oligonucleotide Synthesis New Market Entrants and Barriers to Market Entry
Table 83. Oligonucleotide Synthesis Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Oligonucleotide Synthesis Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global Oligonucleotide Synthesis Consumption Value Share by Type (2018-2023)
Table 86. Global Oligonucleotide Synthesis Consumption Value Forecast by Type (2024-2029)
Table 87. Global Oligonucleotide Synthesis Consumption Value by End User (2018-2023)
Table 88. Global Oligonucleotide Synthesis Consumption Value Forecast by End User (2024-2029)
Table 89. North America Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 92. North America Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 93. North America Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 98. Europe Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 99. Europe Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 104. Asia-Pacific Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 105. Asia-Pacific Oligonucleotide Synthesis Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific Oligonucleotide Synthesis Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 110. South America Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 111. South America Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 116. Middle East & Africa Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 117. Middle East & Africa Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
Table 119. Oligonucleotide Synthesis Raw Material
Table 120. Key Suppliers of Oligonucleotide Synthesis Raw Materials
Table 1. Global Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oligonucleotide Synthesis Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oligonucleotide Synthesis Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oligonucleotide Synthesis Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Integrated DNA Technologies Company Information, Head Office, and Major Competitors
Table 6. Integrated DNA Technologies Major Business
Table 7. Integrated DNA Technologies Oligonucleotide Synthesis Product and Solutions
Table 8. Integrated DNA Technologies Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Integrated DNA Technologies Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Oligonucleotide Synthesis Product and Solutions
Table 13. Merck Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Merck Recent Developments and Future Plans
Table 15. Eurofins Genomics Company Information, Head Office, and Major Competitors
Table 16. Eurofins Genomics Major Business
Table 17. Eurofins Genomics Oligonucleotide Synthesis Product and Solutions
Table 18. Eurofins Genomics Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Eurofins Genomics Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Oligonucleotide Synthesis Product and Solutions
Table 23. Thermo Fisher Scientific Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 26. Agilent Technologies Major Business
Table 27. Agilent Technologies Oligonucleotide Synthesis Product and Solutions
Table 28. Agilent Technologies Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Agilent Technologies Recent Developments and Future Plans
Table 30. Eurogentec Company Information, Head Office, and Major Competitors
Table 31. Eurogentec Major Business
Table 32. Eurogentec Oligonucleotide Synthesis Product and Solutions
Table 33. Eurogentec Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Eurogentec Recent Developments and Future Plans
Table 35. GE Healthcare Company Information, Head Office, and Major Competitors
Table 36. GE Healthcare Major Business
Table 37. GE Healthcare Oligonucleotide Synthesis Product and Solutions
Table 38. GE Healthcare Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GE Healthcare Recent Developments and Future Plans
Table 40. LGC Biosearch Technologies Company Information, Head Office, and Major Competitors
Table 41. LGC Biosearch Technologies Major Business
Table 42. LGC Biosearch Technologies Oligonucleotide Synthesis Product and Solutions
Table 43. LGC Biosearch Technologies Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. LGC Biosearch Technologies Recent Developments and Future Plans
Table 45. Nitto Denko Avecia Company Information, Head Office, and Major Competitors
Table 46. Nitto Denko Avecia Major Business
Table 47. Nitto Denko Avecia Oligonucleotide Synthesis Product and Solutions
Table 48. Nitto Denko Avecia Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Nitto Denko Avecia Recent Developments and Future Plans
Table 50. Genscript Company Information, Head Office, and Major Competitors
Table 51. Genscript Major Business
Table 52. Genscript Oligonucleotide Synthesis Product and Solutions
Table 53. Genscript Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Genscript Recent Developments and Future Plans
Table 55. Genedesign Company Information, Head Office, and Major Competitors
Table 56. Genedesign Major Business
Table 57. Genedesign Oligonucleotide Synthesis Product and Solutions
Table 58. Genedesign Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Genedesign Recent Developments and Future Plans
Table 60. TriLink Biotechnologies Company Information, Head Office, and Major Competitors
Table 61. TriLink Biotechnologies Major Business
Table 62. TriLink Biotechnologies Oligonucleotide Synthesis Product and Solutions
Table 63. TriLink Biotechnologies Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. TriLink Biotechnologies Recent Developments and Future Plans
Table 65. Bio-Synthesis Company Information, Head Office, and Major Competitors
Table 66. Bio-Synthesis Major Business
Table 67. Bio-Synthesis Oligonucleotide Synthesis Product and Solutions
Table 68. Bio-Synthesis Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Bio-Synthesis Recent Developments and Future Plans
Table 70. ATDBio Company Information, Head Office, and Major Competitors
Table 71. ATDBio Major Business
Table 72. ATDBio Oligonucleotide Synthesis Product and Solutions
Table 73. ATDBio Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. ATDBio Recent Developments and Future Plans
Table 75. Global Oligonucleotide Synthesis Revenue (USD Million) by Players (2018-2023)
Table 76. Global Oligonucleotide Synthesis Revenue Share by Players (2018-2023)
Table 77. Breakdown of Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Oligonucleotide Synthesis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key Oligonucleotide Synthesis Players
Table 80. Oligonucleotide Synthesis Market: Company Product Type Footprint
Table 81. Oligonucleotide Synthesis Market: Company Product Application Footprint
Table 82. Oligonucleotide Synthesis New Market Entrants and Barriers to Market Entry
Table 83. Oligonucleotide Synthesis Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Oligonucleotide Synthesis Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global Oligonucleotide Synthesis Consumption Value Share by Type (2018-2023)
Table 86. Global Oligonucleotide Synthesis Consumption Value Forecast by Type (2024-2029)
Table 87. Global Oligonucleotide Synthesis Consumption Value by End User (2018-2023)
Table 88. Global Oligonucleotide Synthesis Consumption Value Forecast by End User (2024-2029)
Table 89. North America Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 92. North America Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 93. North America Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 98. Europe Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 99. Europe Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 104. Asia-Pacific Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 105. Asia-Pacific Oligonucleotide Synthesis Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific Oligonucleotide Synthesis Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 110. South America Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 111. South America Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa Oligonucleotide Synthesis Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa Oligonucleotide Synthesis Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa Oligonucleotide Synthesis Consumption Value by End User (2018-2023) & (USD Million)
Table 116. Middle East & Africa Oligonucleotide Synthesis Consumption Value by End User (2024-2029) & (USD Million)
Table 117. Middle East & Africa Oligonucleotide Synthesis Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa Oligonucleotide Synthesis Consumption Value by Country (2024-2029) & (USD Million)
Table 119. Oligonucleotide Synthesis Raw Material
Table 120. Key Suppliers of Oligonucleotide Synthesis Raw Materials
LIST OF FIGURES
Figure 1. Oligonucleotide Synthesis Picture
Figure 2. Global Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oligonucleotide Synthesis Consumption Value Market Share by Type in 2022
Figure 4. Custom Oligonucleotides
Figure 5. Pre-designed Oligonucleotides
Figure 6. Global Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Oligonucleotide Synthesis Consumption Value Market Share by End User in 2022
Figure 8. Academic Research Institutes Picture
Figure 9. Pharmaceutical and Biotechnology Companies Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Others Picture
Figure 12. Global Oligonucleotide Synthesis Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Oligonucleotide Synthesis Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Oligonucleotide Synthesis Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Oligonucleotide Synthesis Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Oligonucleotide Synthesis Consumption Value Market Share by Region in 2022
Figure 17. North America Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Oligonucleotide Synthesis Revenue Share by Players in 2022
Figure 23. Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Oligonucleotide Synthesis Market Share in 2022
Figure 25. Global Top 6 Players Oligonucleotide Synthesis Market Share in 2022
Figure 26. Global Oligonucleotide Synthesis Consumption Value Share by Type (2018-2023)
Figure 27. Global Oligonucleotide Synthesis Market Share Forecast by Type (2024-2029)
Figure 28. Global Oligonucleotide Synthesis Consumption Value Share by End User (2018-2023)
Figure 29. Global Oligonucleotide Synthesis Market Share Forecast by End User (2024-2029)
Figure 30. North America Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 32. North America Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 38. Europe Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 40. France Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 46. Asia-Pacific Oligonucleotide Synthesis Consumption Value Market Share by Region (2018-2029)
Figure 47. China Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 50. India Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 55. South America Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 60. Middle East and Africa Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 64. Oligonucleotide Synthesis Market Drivers
Figure 65. Oligonucleotide Synthesis Market Restraints
Figure 66. Oligonucleotide Synthesis Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Oligonucleotide Synthesis in 2022
Figure 69. Manufacturing Process Analysis of Oligonucleotide Synthesis
Figure 70. Oligonucleotide Synthesis Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Oligonucleotide Synthesis Picture
Figure 2. Global Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oligonucleotide Synthesis Consumption Value Market Share by Type in 2022
Figure 4. Custom Oligonucleotides
Figure 5. Pre-designed Oligonucleotides
Figure 6. Global Oligonucleotide Synthesis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Oligonucleotide Synthesis Consumption Value Market Share by End User in 2022
Figure 8. Academic Research Institutes Picture
Figure 9. Pharmaceutical and Biotechnology Companies Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Others Picture
Figure 12. Global Oligonucleotide Synthesis Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Oligonucleotide Synthesis Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Oligonucleotide Synthesis Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Oligonucleotide Synthesis Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Oligonucleotide Synthesis Consumption Value Market Share by Region in 2022
Figure 17. North America Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Oligonucleotide Synthesis Revenue Share by Players in 2022
Figure 23. Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Oligonucleotide Synthesis Market Share in 2022
Figure 25. Global Top 6 Players Oligonucleotide Synthesis Market Share in 2022
Figure 26. Global Oligonucleotide Synthesis Consumption Value Share by Type (2018-2023)
Figure 27. Global Oligonucleotide Synthesis Market Share Forecast by Type (2024-2029)
Figure 28. Global Oligonucleotide Synthesis Consumption Value Share by End User (2018-2023)
Figure 29. Global Oligonucleotide Synthesis Market Share Forecast by End User (2024-2029)
Figure 30. North America Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 32. North America Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 38. Europe Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 40. France Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 46. Asia-Pacific Oligonucleotide Synthesis Consumption Value Market Share by Region (2018-2029)
Figure 47. China Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 50. India Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 55. South America Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Oligonucleotide Synthesis Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Oligonucleotide Synthesis Consumption Value Market Share by End User (2018-2029)
Figure 60. Middle East and Africa Oligonucleotide Synthesis Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Oligonucleotide Synthesis Consumption Value (2018-2029) & (USD Million)
Figure 64. Oligonucleotide Synthesis Market Drivers
Figure 65. Oligonucleotide Synthesis Market Restraints
Figure 66. Oligonucleotide Synthesis Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Oligonucleotide Synthesis in 2022
Figure 69. Manufacturing Process Analysis of Oligonucleotide Synthesis
Figure 70. Oligonucleotide Synthesis Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
